Azenta reports earnings soon: what investors expect from AZTA
Azenta releases quarterly results after the market close. The market expects revenue flat year on year, and the company has missed analyst revenue estimates several times.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Life sciences company Azenta will report quarterly results after the market close tomorrow, according to stockstory.org. Last quarter revenue rose 12% to $161.2 million and earnings per share beat analyst estimates. This quarter the market expects revenue to be flat year on year, an improvement on the 6.5% decline recorded a year earlier.
Analysts have mostly kept their estimates unchanged over the past 30 days. However, the company has missed Wall Street revenue forecasts several times over the last two years. Peers in drug development inputs and services, including West Pharmaceutical Services and UFP Technologies, have already reported results above expectations.
why it matters
Investors will watch the company's commentary on its outlook as closely as the quarterly figures. Analyst estimates are already reflected in the share price, so a clear miss or beat could move the stock noticeably.
tags
instruments
sources
- Azenta earnings: what to look for from AZTA — stockstory.org, 9 November 2026 at 09:11 UTC
- Gevo earnings: what to look for from GEVO — stockstory.org, 9 November 2026 at 09:11 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗